Expert Interview
Delving into the phase 2 SEQUOIA trial data on Fazirsiran by Arrowhead Pharmaceuticals and its potential in A1AT liver disease
Ticker(s): ARWRInstitution: Columbia University
- Director of Hepatology Outreach at NY Presbyterian Hospital, Columbia University Medical Center and former medical director of Adult Liver Transplantation at The Montefiore Medical Center
- Has published multiple manuscripts, book chapters, and abstracts, and has participated in numerous research trials related to the therapy of hepatitis B and C, liver transplantation, and treatment of liver failure.
- Fellow of the American College of Physicians, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
